Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Tonogenchoncel-L

Generic Name: Tonogenchoncel-L

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study to Determine the Safety and Efficacy of TG-C in Subjects with Symptomatic Early Hip Osteoarthritis

Phase 2

Not yet recruiting

Posted: 2022/03/11

Sponsor:Kolon TissueGene, In...

ID:NCT05276011

Study to Determine the Efficacy and Safety of TG-C in Subjects with Kellgren/Lawrence Grade 2 or 3 OA of the Knee

Phase 3

Active, not recruiting

Posted: 2017/09/25

Sponsor:Kolon TissueGene, In...

ID:NCT03291470

A Study to Determine the Safety and Efficacy of TG-C in Subjects with Kellgren and Lawrence Grade 2 or 3 OA of the Knee

Phase 3

Active, not recruiting

Posted: 2017/06/29

Sponsor:Kolon TissueGene, In...

ID:NCT03203330

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

TG-C Shows Promise as First Disease-Modifying Therapy for Knee Osteoarthritis with 15-Year Safety Data

a month ago

Kolon TissueGene presented 15-year safety data for TG-C, the world's first cell and gene therapy for osteoarthritis, showing no treatment-related tumors and lower cancer rates compared to the general population.

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy